Regarding the relationship between prevalence and positive predictive value (PPV) in a diagnostic test, all of the following statements are correct EXCEPT:

## Understanding PPV and Its Determinants **Key Point:** PPV is NOT independent of sensitivity and specificity — it is directly derived from both these test characteristics AND disease prevalence. ### PPV Formula and Components The relationship is captured by: $$PPV = \frac{TP}{TP+FP} = \frac{Sensitivity \times Prevalence}{Sensitivity \times Prevalence + (1-Specificity) \times (1-Prevalence)}$$ **High-Yield:** PPV depends on THREE factors: 1. **Sensitivity** of the test 2. **Specificity** of the test 3. **Prevalence** of disease in the population ### Why Each Statement Is Correct (Except One) | Statement | Validity | Explanation | |-----------|----------|-------------| | PPV increases with prevalence | ✓ Correct | Higher disease prevalence → more true positives → higher PPV | | PPV independent of sensitivity/specificity | ✗ **WRONG** | PPV is mathematically derived from both; it cannot exist without them | | Low prevalence → low PPV (even with good test) | ✓ Correct | The denominator (TP+FP) becomes dominated by false positives | | PPV = probability of disease given positive test | ✓ Correct | This is the definition of PPV | ### Clinical Pearl In a low-prevalence setting (e.g., screening for rare disease), false positives outnumber true positives, making PPV low regardless of test quality. This is why screening tests require high specificity in low-prevalence populations. **Mnemonic:** **SNOUT and SPIN** - **SNOUT** = **S**ensitivity rules **OUT** (high sensitivity → low false negative rate) - **SPIN** = **SP**ecificity rules **IN** (high specificity → low false positive rate, high PPV) But remember: PPV and NPV ALWAYS depend on prevalence, sensitivity, AND specificity together.